P.V. NANO CELL LTD. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1449 USD | +4,040.00% |
|
0.00% | +2,686.54% |
| May. 09 | P.V. Nano Cell Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Jan. 16 | P.V. Nano Cell Ltd. Announces Resignation of Fernando De La Vega from Board of Directors | CI |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 6.958 | 2.672 | 6.453 | 0.002738 | 3.996 | 0.9272 |
| Enterprise Value (EV) 1 | 8.882 | 6.975 | 13.08 | 1.965 | 5.279 | 2.118 |
| P/E ratio | -3.52 x | -0.67 x | -0.49 x | -0 x | -0.86 x | -0.42 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 15.1 x | 5.58 x | 8.48 x | 0 x | 6.62 x | 1.94 x |
| EV / Revenue | 19.3 x | 14.6 x | 17.2 x | 3.45 x | 8.75 x | 4.43 x |
| EV / EBITDA | -3.7 x | -2.9 x | -6.63 x | -0.94 x | -2.16 x | -1.12 x |
| EV / FCF | -4.3 x | -5.16 x | 2.16 x | -0.17 x | -2.95 x | -1.34 x |
| FCF Yield | -23.2% | -19.4% | 46.4% | -591% | -33.9% | -74.7% |
| Price to Book | 2.61 x | -2.7 x | -0.5 x | -0.01 x | -3.14 x | -1.05 x |
| Nbr of stocks (in thousands) | 23,194 | 24,287 | 26,886 | 27,385 | 133,206 | 178,300 |
| Reference price 2 | 0.3000 | 0.1100 | 0.2400 | 0.000100 | 0.0300 | 0.005200 |
| Announcement Date | 5/15/19 | 4/29/21 | 5/16/22 | 6/21/22 | 5/15/23 | 5/9/24 |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 0.4607 | 0.4785 | 0.7613 | 0.5687 | 0.6034 | 0.4786 |
| EBITDA 1 | -2.402 | -2.409 | -1.973 | -2.086 | -2.442 | -1.894 |
| EBIT 1 | -3.022 | -2.911 | -2.464 | -2.57 | -2.93 | -1.943 |
| Operating Margin | -655.83% | -608.26% | -323.65% | -451.86% | -485.55% | -405.91% |
| Earnings before Tax (EBT) 1 | -1.973 | -3.953 | -12.54 | -2.519 | -4.51 | -2.072 |
| Net income 1 | -1.973 | -3.953 | -12.54 | -2.519 | -4.51 | -2.072 |
| Net margin | -428.13% | -826.09% | -1,647.63% | -442.91% | -747.41% | -432.94% |
| EPS 2 | -0.0852 | -0.1642 | -0.4904 | -0.0567 | -0.0349 | -0.0124 |
| Free Cash Flow 1 | -2.063 | -1.352 | 6.067 | -11.62 | -1.79 | -1.583 |
| FCF margin | -447.79% | -282.48% | 796.9% | -2,042.79% | -296.6% | -330.7% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 5/15/19 | 4/29/21 | 5/16/22 | 6/21/22 | 5/15/23 | 5/9/24 |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 1.92 | 4.3 | 6.63 | 1.96 | 1.28 | 1.19 |
| Net Cash position 1 | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | -0.8009 x | -1.787 x | -3.362 x | -0.9404 x | -0.5253 x | -0.629 x |
| Free Cash Flow 1 | -2.06 | -1.35 | 6.07 | -11.6 | -1.79 | -1.58 |
| ROE (net income / shareholders' equity) | -71.7% | -463% | 181% | 36.3% | 372% | 179% |
| ROA (Net income/ Total Assets) | -23.3% | -24.7% | -22.6% | -25.5% | -36.3% | -28.6% |
| Assets 1 | 8.483 | 16 | 55.56 | 9.872 | 12.41 | 7.236 |
| Book Value Per Share 2 | 0.1200 | -0.0400 | -0.4800 | -0.0100 | -0.0100 | -0 |
| Cash Flow per Share 2 | 0.0100 | 0 | 0 | 0 | 0 | 0 |
| Capex 1 | 0.02 | 0.01 | 0 | 0 | 0.09 | 0.02 |
| Capex / Sales | 3.96% | 2.49% | 0.38% | 0.33% | 15.44% | 3.33% |
| Announcement Date | 5/15/19 | 4/29/21 | 5/16/22 | 6/21/22 | 5/15/23 | 5/9/24 |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| +2,686.54% | 678K | |
| +17.41% | 66.74B | |
| +3.73% | 49.42B | |
| +21.67% | 42.17B | |
| +21.48% | 26.37B | |
| +10.57% | 19.17B | |
| -2.25% | 16.73B | |
| +5.88% | 15.99B | |
| -14.02% | 14.86B | |
| -27.16% | 14.85B |
- Stock Market
- Equities
- PVNNF Stock
- Financials P.V. Nano Cell Ltd.
